Emergence of advanced immunotherapy: New horizons for HPV-negative head and neck squamous cell carcinoma
Head and neck squamous cell carcinoma (HNSCC) is a complex group of malignancies that exhibit distinct clinical and molecular characteristics, especially in the HPV-negative subset. The treatment landscape for HPV-negative HNSCC has historically been limited to surgery, radiation, and chemotherapy,...
Saved in:
| Main Authors: | Madhan Krishnan, Shyamaladevi Babu, M.V. Vinaya Kumar, Rajasekaran Subbarayan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Oral Oncology Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024005168 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Machine-learning derived identification of prognostic signature to forecast head and neck squamous cell carcinoma prognosis and drug response
by: Sha-Zhou Li, et al.
Published: (2024-12-01) -
Role of Human Papilloma Virus in Carcinogenesis of Head and Neck Squamous Cell
by: Sukri Rahman, et al.
Published: (2024-01-01) -
Neutrophil/lymphocyte ratio: a potential biomarker in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors
by: Marianna Caterino, et al.
Published: (2025-05-01) -
TMCO1, as a potential biomarker of prognosis and immunotherapy response, regulates head and neck squamous cell carcinoma proliferation and migration
by: Ting Li, et al.
Published: (2025-05-01) -
VPS25 Promotes an Immunosuppressive Microenvironment in Head and Neck Squamous Cell Carcinoma
by: Li-Guo Chen, et al.
Published: (2025-02-01)